Drug Name Classification Dosage/ Indication Mechanism Contraindication Adverse Nursing Responsibilities
Frequency of Action Reactions
Vitamin D Therapeutic Class: 0.25 This medication Promotes Contraindicated in Early signs of • Obtain baseline serum
Vitamin D analogue mcg/day is given to the active patients with overdose calcium, ionized calcium,
patient due to absorption hypersensitivity to manifested as phosphorus, alkaline
Pharmacologic the signs and of calcium cholecalciferol, weakness, phosphatase, creatinine, PTH.
Class: Fat-soluble symptoms of ergocalciferol, headache, • Monitor serum, urinary
severe anemia as Vitamin D toxicity drowsiness, calcium levels, serum
evidenced by low and nausea, vomiting, phosphate, magnesium, BUN,
levels of RBC in hypercalcemia dry mouth, creatine, alkaline phosphatase
the patient’s CBC constipation, determinations (therapeutic
taken on muscle/bone pain, calcium level: 9–10 mg/dL),
03/27/23 with a metallic taste. PTH measurements.
result of 2.66. Later signs of • Encourage adequate fluid
This supplement overdose intake.
also helps the evidenced by • Monitor for signs/symptoms
patient absorb polyuria, of vitamin D in- toxication.
calcium as polydipsia, • Report signs/ symptoms of
evidenced by the anorexia, weight hypercalcemia (headache,
low levels of loss, nocturia, weakness, drowsiness, nausea,
calcium in photophobia, vomiting, dry mouth,
the electrolytes rhinorrhea, constipation, metallic taste,
result form of the pruritus, muscle or bone pain)
patient with the disorientation, • Adequate calcium intake
result of 0.74 on hallucinations, should be maintained.
04/12/23. hyperthermia, • Avoid changes in diet or
hypertension, supplemental calcium intake
cardiac (unless directed by health care
dysrhythmias. professional).